Global and Japan GABA Receptor Agonist Drug Market Insights, Forecast to 2026

Global and Japan GABA Receptor Agonist Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 GABA Receptor Agonist Drug Product Introduction
1.2 Market Segments
1.3 Key GABA Receptor Agonist Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Type
1.4.2 Bamaluzole
1.4.3 Phenibut
1.4.4 Baclofen
1.4.5 Gaboxadol
1.4.6 Klonopin (clonazepam)
1.4.7 Tiagbine
1.5 Market by Application
1.5.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Application
1.5.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.5.3 Psychiatric Disorders and Depression
1.5.4 Alzheimer
1.5.5 Epilepsy and Seizure
1.5.6 Anxiety and Sleep Disorders
1.5.7 Obesity and Alcoholism
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global GABA Receptor Agonist Drug Market Size, Estimates and Forecasts
2.1.1 Global GABA Receptor Agonist Drug Revenue 2015-2026
2.1.2 Global GABA Receptor Agonist Drug Sales 2015-2026
2.2 Global GABA Receptor Agonist Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 GABA Receptor Agonist Drug Historical Market Size by Region (2015-2020)
2.3.1 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 GABA Receptor Agonist Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global GABA Receptor Agonist Drug Sales Forecast by Region (2021-2026)
2.4.2 Global GABA Receptor Agonist Drug Revenue Forecast by Region (2021-2026)
3 Global GABA Receptor Agonist Drug Competitor Landscape by Players
3.1 Global Top GABA Receptor Agonist Drug Sales by Manufacturers
3.1.1 Global GABA Receptor Agonist Drug Sales by Manufacturers (2015-2020)
3.1.2 Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global GABA Receptor Agonist Drug Manufacturers by Revenue
3.2.1 Global GABA Receptor Agonist Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global GABA Receptor Agonist Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global GABA Receptor Agonist Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by GABA Receptor Agonist Drug Revenue in 2019
3.2.5 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global GABA Receptor Agonist Drug Price by Manufacturers
3.4 Global GABA Receptor Agonist Drug Manufacturing Base Distribution, Product Types
3.4.1 GABA Receptor Agonist Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers GABA Receptor Agonist Drug Product Type
3.4.3 Date of International Manufacturers Enter into GABA Receptor Agonist Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global GABA Receptor Agonist Drug Market Size by Type (2015-2020)
4.1.1 Global GABA Receptor Agonist Drug Sales by Type (2015-2020)
4.1.2 Global GABA Receptor Agonist Drug Revenue by Type (2015-2020)
4.1.3 GABA Receptor Agonist Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global GABA Receptor Agonist Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Type (2021-2026)
4.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Type (2021-2026)
4.2.3 GABA Receptor Agonist Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global GABA Receptor Agonist Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global GABA Receptor Agonist Drug Market Size by Application (2015-2020)
5.1.1 Global GABA Receptor Agonist Drug Sales by Application (2015-2020)
5.1.2 Global GABA Receptor Agonist Drug Revenue by Application (2015-2020)
5.1.3 GABA Receptor Agonist Drug Price by Application (2015-2020)
5.2 GABA Receptor Agonist Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Application (2021-2026)
5.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global GABA Receptor Agonist Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan GABA Receptor Agonist Drug Market Size YoY Growth 2015-2026
6.1.1 Japan GABA Receptor Agonist Drug Sales YoY Growth 2015-2026
6.1.2 Japan GABA Receptor Agonist Drug Revenue YoY Growth 2015-2026
6.1.3 Japan GABA Receptor Agonist Drug Market Share in Global Market 2015-2026
6.2 Japan GABA Receptor Agonist Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top GABA Receptor Agonist Drug Players by Sales (2015-2020)
6.2.2 Japan Top GABA Receptor Agonist Drug Players by Revenue (2015-2020)
6.3 Japan GABA Receptor Agonist Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan GABA Receptor Agonist Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan GABA Receptor Agonist Drug Price by Type (2015-2020)
6.4 Japan GABA Receptor Agonist Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan GABA Receptor Agonist Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan GABA Receptor Agonist Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan GABA Receptor Agonist Drug Price Forecast by Type (2021-2026)
6.5 Japan GABA Receptor Agonist Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan GABA Receptor Agonist Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan GABA Receptor Agonist Drug Price by Application (2015-2020)
6.6 Japan GABA Receptor Agonist Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan GABA Receptor Agonist Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan GABA Receptor Agonist Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan GABA Receptor Agonist Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America GABA Receptor Agonist Drug Market Size YoY Growth 2015-2026
7.2 North America GABA Receptor Agonist Drug Market Facts & Figures by Country
7.2.1 North America GABA Receptor Agonist Drug Sales by Country (2015-2020)
7.2.2 North America GABA Receptor Agonist Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe GABA Receptor Agonist Drug Market Size YoY Growth 2015-2026
8.2 Europe GABA Receptor Agonist Drug Market Facts & Figures by Country
8.2.1 Europe GABA Receptor Agonist Drug Sales by Country
8.2.2 Europe GABA Receptor Agonist Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific GABA Receptor Agonist Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific GABA Receptor Agonist Drug Market Facts & Figures by Country
9.2.1 Asia Pacific GABA Receptor Agonist Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America GABA Receptor Agonist Drug Market Size YoY Growth 2015-2026
10.2 Latin America GABA Receptor Agonist Drug Market Facts & Figures by Country
10.2.1 Latin America GABA Receptor Agonist Drug Sales by Country
10.2.2 Latin America GABA Receptor Agonist Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa GABA Receptor Agonist Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa GABA Receptor Agonist Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Country
11.2.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Advicenne
12.1.1 Advicenne Corporation Information
12.1.2 Advicenne Description and Business Overview
12.1.3 Advicenne Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
12.1.5 Advicenne Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca GABA Receptor Agonist Drug Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Athena Drug Delivery Solutions
12.3.1 Athena Drug Delivery Solutions Corporation Information
12.3.2 Athena Drug Delivery Solutions Description and Business Overview
12.3.3 Athena Drug Delivery Solutions Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Products Offered
12.3.5 Athena Drug Delivery Solutions Recent Development
12.4 Biocodex
12.4.1 Biocodex Corporation Information
12.4.2 Biocodex Description and Business Overview
12.4.3 Biocodex Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biocodex GABA Receptor Agonist Drug Products Offered
12.4.5 Biocodex Recent Development
12.5 Elan Corporation
12.5.1 Elan Corporation Corporation Information
12.5.2 Elan Corporation Description and Business Overview
12.5.3 Elan Corporation Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Elan Corporation GABA Receptor Agonist Drug Products Offered
12.5.5 Elan Corporation Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Corporation Information
12.6.2 Eli Lilly and Company Description and Business Overview
12.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Products Offered
12.6.5 Eli Lilly and Company Recent Development
12.7 H.LundBeck, Merck and Co
12.7.1 H.LundBeck, Merck and Co Corporation Information
12.7.2 H.LundBeck, Merck and Co Description and Business Overview
12.7.3 H.LundBeck, Merck and Co Sales, Revenue and Gross Margin (2015-2020)
12.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Products Offered
12.7.5 H.LundBeck, Merck and Co Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Description and Business Overview
12.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 NovaDel Pharma
12.9.1 NovaDel Pharma Corporation Information
12.9.2 NovaDel Pharma Description and Business Overview
12.9.3 NovaDel Pharma Sales, Revenue and Gross Margin (2015-2020)
12.9.4 NovaDel Pharma GABA Receptor Agonist Drug Products Offered
12.9.5 NovaDel Pharma Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis GABA Receptor Agonist Drug Products Offered
12.10.5 Novartis Recent Development
12.11 Advicenne
12.11.1 Advicenne Corporation Information
12.11.2 Advicenne Description and Business Overview
12.11.3 Advicenne Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Advicenne GABA Receptor Agonist Drug Products Offered
12.11.5 Advicenne Recent Development
12.12 Osmotica Pharmaceutical
12.12.1 Osmotica Pharmaceutical Corporation Information
12.12.2 Osmotica Pharmaceutical Description and Business Overview
12.12.3 Osmotica Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Osmotica Pharmaceutical Products Offered
12.12.5 Osmotica Pharmaceutical Recent Development
12.13 Pfizer
12.13.1 Pfizer Corporation Information
12.13.2 Pfizer Description and Business Overview
12.13.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pfizer Products Offered
12.13.5 Pfizer Recent Development
12.14 sanofi-aventis
12.14.1 sanofi-aventis Corporation Information
12.14.2 sanofi-aventis Description and Business Overview
12.14.3 sanofi-aventis Sales, Revenue and Gross Margin (2015-2020)
12.14.4 sanofi-aventis Products Offered
12.14.5 sanofi-aventis Recent Development
12.15 VIVUS
12.15.1 VIVUS Corporation Information
12.15.2 VIVUS Description and Business Overview
12.15.3 VIVUS Sales, Revenue and Gross Margin (2015-2020)
12.15.4 VIVUS Products Offered
12.15.5 VIVUS Recent Development
12.16 XenoPort
12.16.1 XenoPort Corporation Information
12.16.2 XenoPort Description and Business Overview
12.16.3 XenoPort Sales, Revenue and Gross Margin (2015-2020)
12.16.4 XenoPort Products Offered
12.16.5 XenoPort Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key GABA Receptor Agonist Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 GABA Receptor Agonist Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. GABA Receptor Agonist Drug Market Segments
Table 2. Ranking of Global Top GABA Receptor Agonist Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global GABA Receptor Agonist Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Bamaluzole
Table 5. Major Manufacturers of Phenibut
Table 6. Major Manufacturers of Baclofen
Table 7. Major Manufacturers of Gaboxadol
Table 8. Major Manufacturers of Klonopin (clonazepam)
Table 9. Major Manufacturers of Tiagbine
Table 10. Global GABA Receptor Agonist Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global GABA Receptor Agonist Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global GABA Receptor Agonist Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global GABA Receptor Agonist Drug Sales Market Share by Regions (2015-2020)
Table 14. Global GABA Receptor Agonist Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global GABA Receptor Agonist Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global GABA Receptor Agonist Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global GABA Receptor Agonist Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global GABA Receptor Agonist Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA Receptor Agonist Drug as of 2019)
Table 20. GABA Receptor Agonist Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. GABA Receptor Agonist Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers GABA Receptor Agonist Drug Price (2015-2020) (USD/Pcs)
Table 23. GABA Receptor Agonist Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers GABA Receptor Agonist Drug Product Type
Table 25. Date of International Manufacturers Enter into GABA Receptor Agonist Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 28. Global GABA Receptor Agonist Drug Sales Share by Type (2015-2020)
Table 29. Global GABA Receptor Agonist Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global GABA Receptor Agonist Drug Revenue Share by Type (2015-2020)
Table 31. GABA Receptor Agonist Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global GABA Receptor Agonist Drug Sales Share by Type (2021-2026)
Table 33. Global GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 34. Global GABA Receptor Agonist Drug Sales Share by Application (2015-2020)
Table 35. Global GABA Receptor Agonist Drug Sales Share by Application (2021-2026)
Table 36. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Application (2021-2026)
Table 37. Global GABA Receptor Agonist Drug Revenue by Application (2015-2020) (US$ Million)
Table 38. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan GABA Receptor Agonist Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 40. Japan GABA Receptor Agonist Drug Sales Share by Company (2015-2020)
Table 41. Japan GABA Receptor Agonist Drug Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan GABA Receptor Agonist Drug Sales (K Pcs) by Type (2015-2020)
Table 43. Japan GABA Receptor Agonist Drug Sales Share by Type (2015-2020)
Table 44. Japan GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan GABA Receptor Agonist Drug Price (K Pcs) by Type (2015-2020)
Table 46. Japan GABA Receptor Agonist Drug Sales (K Pcs) by Type (2021-2026)
Table 47. Japan GABA Receptor Agonist Drug Sales Share by Type (2021-2026)
Table 48. Japan GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan GABA Receptor Agonist Drug Revenue Share by Type (2021-2026)
Table 50. Japan GABA Receptor Agonist Drug Price (K Pcs) by Type (2021-2026)
Table 51. Japan GABA Receptor Agonist Drug Sales (K Pcs) by Application (2015-2020)
Table 52. Japan GABA Receptor Agonist Drug Sales Share by Application (2015-2020)
Table 53. Japan GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan GABA Receptor Agonist Drug Sales (K Pcs) by Application (2021-2026)
Table 55. Japan GABA Receptor Agonist Drug Sales Share by Application (2021-2026)
Table 56. Japan GABA Receptor Agonist Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan GABA Receptor Agonist Drug Revenue Share by Application (2021-2026)
Table 58. North America GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 59. North America GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 60. North America GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. North America GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 62. Europe GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 63. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 64. Europe GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific GABA Receptor Agonist Drug Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific GABA Receptor Agonist Drug Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific GABA Receptor Agonist Drug Revenue Market Share by Region (2015-2020)
Table 70. Latin America GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 78. Advicenne Corporation Information
Table 79. Advicenne Description and Business Overview
Table 80. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Advicenne GABA Receptor Agonist Drug Product
Table 82. Advicenne Recent Development
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Business Overview
Table 85. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. AstraZeneca Product
Table 87. AstraZeneca Recent Development
Table 88. Athena Drug Delivery Solutions Corporation Information
Table 89. Athena Drug Delivery Solutions Description and Business Overview
Table 90. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Athena Drug Delivery Solutions Product
Table 92. Athena Drug Delivery Solutions Recent Development
Table 93. Biocodex Corporation Information
Table 94. Biocodex Description and Business Overview
Table 95. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Biocodex Product
Table 97. Biocodex Recent Development
Table 98. Elan Corporation Corporation Information
Table 99. Elan Corporation Description and Business Overview
Table 100. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Elan Corporation Product
Table 102. Elan Corporation Recent Development
Table 103. Eli Lilly and Company Corporation Information
Table 104. Eli Lilly and Company Description and Business Overview
Table 105. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Eli Lilly and Company Product
Table 107. Eli Lilly and Company Recent Development
Table 108. H.LundBeck, Merck and Co Corporation Information
Table 109. H.LundBeck, Merck and Co Description and Business Overview
Table 110. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. H.LundBeck, Merck and Co Product
Table 112. H.LundBeck, Merck and Co Recent Development
Table 113. GlaxoSmithKline Corporation Information
Table 114. GlaxoSmithKline Description and Business Overview
Table 115. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. GlaxoSmithKline Product
Table 117. GlaxoSmithKline Recent Development
Table 118. NovaDel Pharma Corporation Information
Table 119. NovaDel Pharma Description and Business Overview
Table 120. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. NovaDel Pharma Product
Table 122. NovaDel Pharma Recent Development
Table 123. Novartis Corporation Information
Table 124. Novartis Description and Business Overview
Table 125. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Novartis Product
Table 127. Novartis Recent Development
Table 128. OVATION Pharmaceuticals Corporation Information
Table 129. OVATION Pharmaceuticals Description and Business Overview
Table 130. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. OVATION Pharmaceuticals Product
Table 132. OVATION Pharmaceuticals Recent Development
Table 133. Osmotica Pharmaceutical Corporation Information
Table 134. Osmotica Pharmaceutical Description and Business Overview
Table 135. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Osmotica Pharmaceutical Product
Table 137. Osmotica Pharmaceutical Recent Development
Table 138. Pfizer Corporation Information
Table 139. Pfizer Description and Business Overview
Table 140. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Pfizer Product
Table 142. Pfizer Recent Development
Table 143. sanofi-aventis Corporation Information
Table 144. sanofi-aventis Description and Business Overview
Table 145. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. sanofi-aventis Product
Table 147. sanofi-aventis Recent Development
Table 148. VIVUS Corporation Information
Table 149. VIVUS Description and Business Overview
Table 150. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. VIVUS Product
Table 152. VIVUS Recent Development
Table 153. XenoPort Corporation Information
Table 154. XenoPort Description and Business Overview
Table 155. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. XenoPort Product
Table 157. XenoPort Recent Development
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key GABA Receptor Agonist Drug Players
Table 162. GABA Receptor Agonist Drug Customers List
Table 163. GABA Receptor Agonist Drug Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. GABA Receptor Agonist Drug Product Picture
Figure 2. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Bamaluzole Product Picture
Figure 4. Phenibut Product Picture
Figure 5. Baclofen Product Picture
Figure 6. Gaboxadol Product Picture
Figure 7. Klonopin (clonazepam) Product Picture
Figure 8. Tiagbine Product Picture
Figure 9. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 11. Psychiatric Disorders and Depression
Figure 12. Alzheimer
Figure 13. Epilepsy and Seizure
Figure 14. Anxiety and Sleep Disorders
Figure 15. Obesity and Alcoholism
Figure 16. GABA Receptor Agonist Drug Report Years Considered
Figure 17. Global GABA Receptor Agonist Drug Market Size 2015-2026 (US$ Million)
Figure 18. Global GABA Receptor Agonist Drug Sales 2015-2026 (K Pcs)
Figure 19. Global GABA Receptor Agonist Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global GABA Receptor Agonist Drug Sales Market Share by Region (2015-2020)
Figure 21. Global GABA Receptor Agonist Drug Sales Market Share by Region in 2019
Figure 22. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2015-2020)
Figure 23. Global GABA Receptor Agonist Drug Revenue Market Share by Region in 2019
Figure 24. Global GABA Receptor Agonist Drug Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by GABA Receptor Agonist Drug Revenue in 2019
Figure 26. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Figure 28. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2019
Figure 29. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2015-2020)
Figure 30. Global GABA Receptor Agonist Drug Revenue Market Share by Type in 2019
Figure 31. Global GABA Receptor Agonist Drug Market Share by Price Range (2015-2020)
Figure 32. Global GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Figure 33. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2019
Figure 34. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2015-2020)
Figure 35. Global GABA Receptor Agonist Drug Revenue Market Share by Application in 2019
Figure 36. Japan GABA Receptor Agonist Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 37. Japan GABA Receptor Agonist Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 38. Japan GABA Receptor Agonist Drug Market Share in Global Market 2015-2026
Figure 39. Japan 5 and 10 Largest GABA Receptor Agonist Drug Players Market Share by Revenue in GABA Receptor Agonist Drug in 2019
Figure 40. Japan GABA Receptor Agonist Drug Revenue Share by Type (2015-2020)
Figure 41. Japan GABA Receptor Agonist Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 42. Japan GABA Receptor Agonist Drug Revenue Share by Application (2015-2020)
Figure 43. Japan GABA Receptor Agonist Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 44. North America GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. North America GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. North America GABA Receptor Agonist Drug Sales Market Share by Country in 2019
Figure 47. North America GABA Receptor Agonist Drug Revenue Market Share by Country in 2019
Figure 48. U.S. GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.S. GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Canada GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 53. Europe GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 54. Europe GABA Receptor Agonist Drug Sales Market Share by Country in 2019
Figure 55. Europe GABA Receptor Agonist Drug Revenue Market Share by Country in 2019
Figure 56. Germany GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Germany GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. France GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. France GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. U.K. GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. U.K. GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Italy GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Russia GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Russia GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Asia Pacific GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 67. Asia Pacific GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 68. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Region in 2019
Figure 69. Asia Pacific GABA Receptor Agonist Drug Revenue Market Share by Region in 2019
Figure 70. China GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. China GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Japan GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Japan GABA Receptor Agonist Drug Revenue Growth Rat

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs